Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 206

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments

Open access
Yu, Jong W., Bhattacharya, Sabyasachi, Yanamandra, Niranjan, Kilian, David, Shi, Hong, Yadavilli, Sapna, Katlinskaya, Yuliya, Kaczynski, Heather, Conner, Michael, Benson, William, Hahn, Ashleigh, Seestaller-Wehr, Laura, Bi, Meixia, Vitali, Nicholas J., Tsvetkov, Lyuben, Halsey, Wendy, Hughes, Ashley, Traini, Christopher, Zhou, Hui, Jing, Junping, Lee, Tae, Figueroa, David J., Brett, Sara, Hopson, Christopher B., Smothers, James F., Hoos, Axel, Srinivasan, Roopa · 2018 · PLOS ONE

Abstract

Mouse syngeneic tumor models are widely used tools to demonstrate activity of novel anti-cancer immunotherapies. Despite their widespread use, a comprehensive view of their tumor-immune compositions and their relevance to human tumors has only begun to emerge. We propose each model possesses a unique tumor-immune infiltrate profile that can be probed with immunotherapies to inform on anti-tumor mechanisms and treatment strategies in human tumors with similar profiles. In support of this endeavor, we characterized the tumor microenvironment of four commonly used models and demonstrate they encompass a range of immunogenicities, from highly immune infiltrated RENCA tumors to poorly infiltrated B16F10 tumors. Tumor cell lines for each model exhibit different intrinsic factors in vitro that likely influence immune infiltration upon subcutaneous implantation. Similarly, solid tumors in vivo for each model are unique, each enriched in distinct features ranging from pathogen response elements to antigen presentation machinery. As RENCA tumors progress in size, all major T cell populations diminish while myeloid-derived suppressor cells become more enriched, possibly driving immune suppression and tumor progression. In CT26 tumors, CD8 T cells paradoxically increase in density yet are restrained as tumor volume increases. Finally, immunotherapy treatment across these different tumor-immune landscapes segregate into responders and non-responders based on features partially dependent on pre-existing immune infiltrates. Overall, these studies provide an important resource to enhance our translation of syngeneic models to human tumors. Future mechanistic studies paired with this resource will help identify responsive patient populations and improve strategies where immunotherapies are predicted to be ineffective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0206223

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 206

Metadata

Authors
Yu, J. W., Bhattacharya, S., Yanamandra, N., Kilian, D., Shi, H., Yadavilli, S., Katlinskaya, Y., Kaczynski, H., Conner, M., Benson, W., Hahn, A., Seestaller-Wehr, L., Bi, M., Vitali, N. J., Tsvetkov, L., Halsey, W., Hughes, A., Traini, C., Zhou, H., Jing, J., Lee, T., Figueroa, D. J., Brett, S., Hopson, C. B., Smothers, J. F., Hoos, A., & Srinivasan, R.
Venue
PLOS ONE
Published
2018-11-02
Volume
13
Issue
11
Pages
e0206223
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2898701288
Cited by
206
References
21
FWCI
5.98
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. https://app.cochat.ai/papers/10.1371/journal.pone.0206223
The paper
Yu, J. W., Bhattacharya, S., Yanamandra, N., Kilian, D., Shi, H., Yadavilli, S., Katlinskaya, Y., Kaczynski, H., Conner, M., Benson, W., Hahn, A., Seestaller-Wehr, L., Bi, M., Vitali, N. J., Tsvetkov, L., Halsey, W., Hughes, A., Traini, C., Zhou, H., . . . Srinivasan, R. (2018). Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. PLOS ONE. https://doi.org/10.1371/journal.pone.0206223

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.